GRI Bio
5 hedge funds and large institutions have $15.5K invested in GRI Bio in 2025 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 3
Holders
5
Holding in Top 10
–
Calls
–
Puts
–
Top Sellers
| 1 | -$63.1K | |
| 2 | -$25K | |
| 3 | -$13.1K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$6.98K |
| 5 |
SS
SBI Securities
Tokyo,
Japan
|
-$3 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
UBS Group
Zurich,
Switzerland
| $10.4K |
|
|||
|
TRCT
2
Tower Research Capital (TRC)
New York
| $4.07K |
|
|||
3
BlackRock
New York
| $675 |
|
|||
|
SS
4
SBI Securities
Tokyo,
Japan
| $374 |
|
|||
5
Bank of America
Charlotte,
North Carolina
| $13 |
|
|||
6
Geode Capital Management
Boston,
Massachusetts
| – |
|
|||
|
VF
7
Virtu Financial
New York
| – |
|
|||
|
TSS
8
Two Sigma Securities
New York
| – |
|